Episode Details

CVS Health is launching a $29 telehealth consultation to lure patients into its weight-loss drug ecosystem, using the low price as a gateway to lock in long-term prescriptions for GLP-1 meds like Zepbound and Mounjaro—now available with transparent pricing and same-day pickup via its app. By partnering with Eli Lilly and offering out-of-pocket discounts as low as $149/month, CVS aims to capture market share amid soaring demand, even as investors eye whether this aggressive strategy can offset broader business risks.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/b159ae1be17f86d9